Arch Biopartners Announces Dosing of First Patient in Phase II Trial for LSALT Peptide ...

Retrieved on: 2024-03-07 14:50:05

Tags for this article:

Kidney diseases

Organ failure

Kidney transplantation

Organ transplantation

Arch Biopartners, Inc.

Click the tags to see associated articles and topics

Arch Biopartners Announces Dosing of First Patient in Phase II Trial for LSALT Peptide .... View article details on hiswai:

Excerpt

Biotech Bay · Biotech Beach · BioCapital · BioMidwest · Bio NC · BioForest · Genetown · Best Places to Work · Pharm Country · Lone Star Bio · NextGen ...

Article found on: www.biospace.com

View Original Article